Aju Ib Investment Co., Ltd. Rapt Therapeutics, Inc. Transaction History
Aju Ib Investment Co., Ltd.
- $58.4 Million
- Q3 2022
A detailed history of Aju Ib Investment Co., Ltd. transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Aju Ib Investment Co., Ltd. holds 99,503 shares of RAPT stock, worth $303,484. This represents 4.1% of its overall portfolio holdings.
Number of Shares
99,503
Previous 99,503
-0.0%
Holding current value
$303,484
Previous $1.82 Million
31.83%
% of portfolio
4.1%
Previous 3.52%
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
148Shares Held
29.2MCall Options Held
709KPut Options Held
1.06M-
Column Group LLC San Francisco, CA2.68MShares$8.18 Million15.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$7.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$7.54 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.03MShares$6.19 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.91MShares$5.81 Million0.0% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $90.5M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...